Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ondrej Mach

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Vaccine|April 2, 2022
Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaksConcepcion F Estivariz, Stephanie D Kovacs, Ondrej Mach
Pathogens (Basel, Switzerland)|January 8, 2025
Immunodeficiency-Related Vaccine-Derived Poliovirus (iVDPV) Infections: A Review of Epidemiology and Progress in Detection and ManagementConcepcion F Estivariz, Elisabeth R Krow-Lucal, Ondrej Mach
MEDICC Review|May 19, 2018
Cuba's Scientific Contributions to Global Polio EradicationSonia Resik, Ondrej Mach, Alina Tejeda, et al.
The Journal of Infectious Diseases|October 16, 2014
The new polio eradication end game: rationale and supporting evidenceRoland W Sutter, Lauren Platt, Ondrej Mach, et al.
The Journal of Infectious Diseases|October 16, 2014
Outbreaks of paralytic poliomyelitis during 1996-2012: the changing epidemiology of a disease in the final stages of eradicationOndrej Mach, Rudolf H Tangermann, Steve G Wassilak, et al.
Pathogens (Basel, Switzerland)|April 26, 2024
The Last Mile in Polio Eradication: Program Challenges and PerseveranceRocio Lopez Cavestany, Martin Eisenhawer, Ousmane M Diop, et al.
Journal of Epidemiology and Global Health|July 14, 2015
Achieving high seroprevalence against polioviruses in Sri Lanka--results from a serological survey, 2014Deepa Gamage, Paba Palihawadana, Ondrej Mach, et al.
Heliyon|January 16, 2018
Feasibility of conducting intradermal vaccination campaign with inactivated poliovirus vaccine using Tropis intradermal needle free injection system, Karachi, PakistanMohammad Tahir Yousafzai, Ali Faisal Saleem, Ondrej Mach, et al.
The Journal of Infectious Diseases|January 17, 2019
Poliovirus Type 2 Seroprevalence Following Full- or Fractional-Dose Inactivated Poliovirus Vaccine in the Period After Sabin Type 2 Withdrawal in Sri LankaDeepa Gamage, Ondrej Mach, Samitha Ginige, et al.
The Journal of Infectious Diseases|June 14, 2011
South-East Asia Regional update on measles mortality reduction and elimination, 2003-2008Patrick M O'Connor, Jayantha B L Liyanage, Ondrej Mach, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Vaccine|April 2, 2022
Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaksConcepcion F Estivariz, Stephanie D Kovacs, Ondrej Mach
Pathogens (Basel, Switzerland)|January 8, 2025
Immunodeficiency-Related Vaccine-Derived Poliovirus (iVDPV) Infections: A Review of Epidemiology and Progress in Detection and ManagementConcepcion F Estivariz, Elisabeth R Krow-Lucal, Ondrej Mach
MEDICC Review|May 19, 2018
Cuba's Scientific Contributions to Global Polio EradicationSonia Resik, Ondrej Mach, Alina Tejeda, et al.
The Journal of Infectious Diseases|October 16, 2014
The new polio eradication end game: rationale and supporting evidenceRoland W Sutter, Lauren Platt, Ondrej Mach, et al.
The Journal of Infectious Diseases|October 16, 2014
Outbreaks of paralytic poliomyelitis during 1996-2012: the changing epidemiology of a disease in the final stages of eradicationOndrej Mach, Rudolf H Tangermann, Steve G Wassilak, et al.
Pathogens (Basel, Switzerland)|April 26, 2024
The Last Mile in Polio Eradication: Program Challenges and PerseveranceRocio Lopez Cavestany, Martin Eisenhawer, Ousmane M Diop, et al.
Journal of Epidemiology and Global Health|July 14, 2015
Achieving high seroprevalence against polioviruses in Sri Lanka--results from a serological survey, 2014Deepa Gamage, Paba Palihawadana, Ondrej Mach, et al.
Heliyon|January 16, 2018
Feasibility of conducting intradermal vaccination campaign with inactivated poliovirus vaccine using Tropis intradermal needle free injection system, Karachi, PakistanMohammad Tahir Yousafzai, Ali Faisal Saleem, Ondrej Mach, et al.
The Journal of Infectious Diseases|January 17, 2019
Poliovirus Type 2 Seroprevalence Following Full- or Fractional-Dose Inactivated Poliovirus Vaccine in the Period After Sabin Type 2 Withdrawal in Sri LankaDeepa Gamage, Ondrej Mach, Samitha Ginige, et al.
The Journal of Infectious Diseases|June 14, 2011
South-East Asia Regional update on measles mortality reduction and elimination, 2003-2008Patrick M O'Connor, Jayantha B L Liyanage, Ondrej Mach, et al.
Pageof 7